This session will review new CDC 2024 DoxyPEP guidelines, identifying patient populations most likely to benefit from DoxyPEP. The session will discuss pros and cons of DoxyPEP including resistance concerns, and review advances in STI diagnosis and treatment and their clinical implications.
Tanisha Tillery 6179836945
tanisha.l.tillery@mass.gov